Market Overview

Biocept to Present at the 30th Annual ROTH Conference

Share:

SAN DIEGO, March 6, 2018 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that President and CEO Michael W. Nall is scheduled to present a corporate overview at the 30th Annual ROTH Conference on Tuesday, March 13, 2018, at 7:30 a.m. Pacific time (10:30 a.m. Eastern time). The conference is being held at The Ritz Carlton Laguna Niguel hotel in Dana Point, Calif. 

Biocept Logo (PRNewsFoto/Biocept, Inc.)

A live webcast of the corporate presentation will be available on the Company's website at ir.biocept.com. A replay of the presentation will be available for 90 days.

About Biocept

Biocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company uses its proprietary liquid biopsy technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer. The Company's patented Target Selector™ liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in circulating tumor DNA (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient's disease and therapeutic options. For additional information, please visit www.biocept.com 

                                                            

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/biocept-to-present-at-the-30th-annual-roth-conference-300605754.html

SOURCE Biocept, Inc.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com